Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 909
1.
Acta Neurochir Suppl ; 135: 231-240, 2023.
Article En | MEDLINE | ID: mdl-38153475

OBJECTIVE: In recent years, Candida spondylodiscitis has represented an increasingly emerging disease in clinical practice. This condition requires long-term antibiotic therapy and sometimes surgical treatments. The main purpose of this study is to investigate the epidemiology, clinical and radiological aspects, treatment protocols, and outcomes of Candida-mediated vertebral osteomyelitis. METHODS: A systematic review of the English literature was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.The research was conducted on Medline, Cochrane library, PubMed, and Scopus using as search terms "vertebral"; "spinal"; "infection"; "spondylodiscitis"; "discitis"; "osteomyelitis"; "Candida"; and "Candidosis." A case of vertebral candidiasis that was surgically managed was also reported. RESULTS: In total, 88 articles were included in our systematic review. Including the reported case, our analysis covered 113 cases of vertebral candidiasis. Candida albicans was isolated in 64 cases (56.1%), Candida tropicalis in 21 (18.4%), Candida glabrata in 14 (12.3%), and Candida parapsilosis in five (4.4%). The mean duration of the follow-up was 395 days. Finally, 87 (82%) patients completely recovered, ten (9.4%) died, and nine (8.5%) reported sequelae. CONCLUSION: This systematic review summarized the state of the art on vertebral candidiasis, describing data on its clinical features, diagnostic criteria and current limitations, and treatment alternatives and their outcomes.


Candidiasis , Osteomyelitis , Humans , Candidiasis/epidemiology , Candidiasis/therapy , Osteomyelitis/microbiology , Spine/microbiology , Spine/pathology
2.
Mycopathologia ; 188(6): 893-905, 2023 Dec.
Article En | MEDLINE | ID: mdl-37277679

Intravascular diseases due to Candida species, including endocarditis and cardiac device-associated infections, are rare yet devastating manifestations of invasive candidiasis affecting an already vulnerable population. Despite their significant associated morbidity and mortality, limited prospective data exist to inform the optimal diagnostic and therapeutic approaches to these entities. Herein, we review the existing literature pertaining to the epidemiology, diagnosis, and management of infectious endocarditis, rhythm management device infections, and circulatory support device infections caused by Candida species and suggest areas for future research.


Candidiasis , Defibrillators, Implantable , Endocarditis , Humans , Candida , Defibrillators, Implantable/adverse effects , Prospective Studies , Candidiasis/diagnosis , Candidiasis/epidemiology , Candidiasis/therapy , Endocarditis/diagnosis , Endocarditis/epidemiology , Endocarditis/therapy
3.
JAMA ; 329(3): 197-199, 2023 01 17.
Article En | MEDLINE | ID: mdl-36576734

This Medical News feature examines the relatively newly identified fungus Candida auris, a hardy species that can resist treatment with antifungal agents, is highly contagious, and is associated with serious infections and significant mortality.


Candida auris , Candidiasis , Antifungal Agents/therapeutic use , Delivery of Health Care , Microbial Sensitivity Tests , Candidiasis/diagnosis , Candidiasis/microbiology , Candidiasis/therapy
4.
Arch Dermatol Res ; 315(3): 583-591, 2023 Apr.
Article En | MEDLINE | ID: mdl-36245011

Various therapeutic options are available for verruca. While physical destruction may be associated with scarring, immunotherapy may be effective in treating warts through stimulating body immune response. The objective of the study was to compare the efficacy, safety, and outcome of Candida antigen vs diphencyprone (DPCP) in the treatment of warts. Fifty patients were randomly assigned to receive either intralesional Candida antigen every 3 weeks or weekly DPCP application. Both treatments were applied only to the mother wart. Lesions' clearance and associated side effects were observed up to 4 weeks after treatment. Two blinded physicians evaluated photos of warts before and 4 weeks after the end of treatment. Both modalities granted wart clearance and/or improvement with no statistically significant difference; however, Candida antigen was significantly better in clearing adjacent untreated warts (p = 0.046). Fewer side effects were observed among the Candida antigen group. The response was duration associated in the Candida groups only. Intralesional Candida antigen injection and DPCP treatments for warts yielded improvement with superiority of Candida injection in eradicating distant lesions and fewer side effects. A shorter wart duration may be associated with a better therapeutic response with Candida antigen.


Antigens, Fungal , Candidiasis , Drug-Related Side Effects and Adverse Reactions , Vaccines , Warts , Humans , Antigens, Fungal/administration & dosage , Antigens, Fungal/adverse effects , Candida , Immunotherapy/adverse effects , Injections, Intralesional , Treatment Outcome , Vaccines/administration & dosage , Vaccines/adverse effects , Warts/therapy , Cyclopropanes/administration & dosage , Cyclopropanes/adverse effects , Candidiasis/therapy
5.
Arq. bras. neurocir ; 40(4): 412-415, 26/11/2021.
Article En | LILACS | ID: biblio-1362160

Background Fungal spondylodiscitis is not common but should be suspected in some cases. Candida tropicalis infections are being more frequently diagnosed due to some factors related to the microorganism. Case Description A C. tropicalis spondylodiscitis is described in a 72-year-old man who was treated with a combination of echinocandin (micafungin) and surgery. Conclusion The presence of some risk factors should promptly raise the suspicion of fungal spondylodiscitis. Treatment should be instituted as early as possible for the best outcome for the patient.


Humans , Male , Aged , Discitis/surgery , Candida tropicalis/pathogenicity , Micafungin/therapeutic use , Lumbar Vertebrae/surgery , Candidiasis/diagnosis , Candidiasis/therapy , Discitis/diagnostic imaging , Laminectomy/methods
6.
Bioelectrochemistry ; 142: 107921, 2021 Dec.
Article En | MEDLINE | ID: mdl-34419917

Wireless electroceutical dressing (WED) fabric kills bacteria and disrupts bacterial biofilm. This work tested, comparing with standard of care topical antibiotic ketoconazole, whether the weak electric field generated by WED is effective to manage infection caused by ketoconazole-resistant yeast Candida albicans. WED inhibited Candida albicans biofilm formation and planktonic growth. Unlike ketoconazole, WED inhibited yeast to hyphal transition and downregulated EAP1 curbing cell attachment. In response to WED-dependent down-regulation of biofilm-forming BRG1 and ROB1, BCR1 expression was markedly induced in what seems to be a futile compensatory response. WED induced NRG1 and TUP1, negative regulators of filamentation; it down-regulated EFG1, a positive regulator of hyphal pathway. Consistent with the anti-hyphal properties of WED, the expression of ALS3 and HWP1 were diminished. Ketoconazole failed to reproduce the effects of WED on NRG1, TUP1 and EFG1. WED blunted efflux pump activity; this effect was in direct contrast to that of ketoconazole. WED exposure compromised cellular metabolism. In the presence of ketoconazole, the effect was synergistic. Unlike ketoconazole, WED caused membrane depolarization, changes in cell wall composition and loss of membrane integrity. This work presents first evidence that weak electric field is useful in managing pathogens which are otherwise known to be antibiotic resistant.


Bandages/microbiology , Biofilms/growth & development , Candida albicans/metabolism , Candidiasis/therapy , Drug Resistance, Microbial/drug effects , Electrochemical Techniques/methods
7.
BMC Complement Med Ther ; 21(1): 170, 2021 Jun 10.
Article En | MEDLINE | ID: mdl-34112168

BACKGROUND: Facial abscess caused by Candida albicans infection is a rare condition even in immunocompromised patients, and only a few cases have been reported. To our knowledge, this is the first case of multiple facial candidal abscesses caused by self-administered acupuncture in an undiagnosed diabetes mellitus patient. CASE PRESENTATION: A 57-year-old woman who had self-acupuncture treatment 2 weeks previously, presented with a 1-week history of progressive left eyelid swelling, erythema, and pain. Despite the antibiotic treatment, the lesion progressed. Surgical incision and drainage was performed and Candida albicans was isolated from the obtained pus culture. The patient was diagnosed with type 2 diabetes mellitus based on a random serum glucose level of 350 mg/dl and 9.2% HbA1c. The abscess resolved after seven incision and drainage cycles and 4 weeks of intravenous fluconazole treatment with an appropriate control of diabetes mellitus. CONCLUSION: Unusual organisms and underlying immunocompromised condition should be suspected in cases of recurrent abscess showing an inadequate response to antibiotic treatment.


Abscess/microbiology , Acupuncture Therapy/adverse effects , Candidiasis/diagnosis , Diabetes Mellitus, Type 2/diagnosis , Abscess/therapy , Antifungal Agents/therapeutic use , Candidiasis/therapy , Drainage , Female , Fluconazole/therapeutic use , Humans , Middle Aged , Self Administration , Undiagnosed Diseases
8.
J Immunol Res ; 2021: 8280925, 2021.
Article En | MEDLINE | ID: mdl-34036109

BACKGROUND: Candida glabrata is a human opportunistic pathogen that can cause life-threatening systemic infections. Although there are multiple effective vaccines against fungal infections and some of these vaccines are engaged in different stages of clinical trials, none of them have yet been approved by the FDA. AIM: Using immunoinformatics approach to predict the most conserved and immunogenic B- and T-cell epitopes from the fructose bisphosphate aldolase (Fba1) protein of C. glabrata. Material and Method. 13 C. glabrata fructose bisphosphate aldolase protein sequences (361 amino acids) were retrieved from NCBI and presented in several tools on the IEDB server for prediction of the most promising epitopes. Homology modeling and molecular docking were performed. RESULT: The promising B-cell epitopes were AYFKEH, VDKESLYTK, and HVDKESLYTK, while the promising peptides which have high affinity to MHC I binding were AVHEALAPI, KYFKRMAAM, QTSNGGAAY, RMAAMNQWL, and YFKEHGEPL. Two peptides, LFSSHMLDL and YIRSIAPAY, were noted to have the highest affinity to MHC class II that interact with 9 alleles. The molecular docking revealed that the epitopes QTSNGGAAY and LFSSHMLDL have the lowest binding energy to MHC molecules. CONCLUSION: The epitope-based vaccines predicted by using immunoinformatics tools have remarkable advantages over the conventional vaccines in that they are more specific, less time consuming, safe, less allergic, and more antigenic. Further in vivo and in vitro experiments are needed to prove the effectiveness of the best candidate's epitopes (QTSNGGAAY and LFSSHMLDL). To the best of our knowledge, this is the first study that has predicted B- and T-cell epitopes from the Fba1 protein by using in silico tools in order to design an effective epitope-based vaccine against C. glabrata.


Candida glabrata/immunology , Candidiasis/therapy , Fructose-Bisphosphate Aldolase/immunology , Fungal Proteins/immunology , Fungal Vaccines/immunology , Amino Acid Sequence/genetics , Candida glabrata/enzymology , Candida glabrata/genetics , Candidiasis/immunology , Candidiasis/microbiology , Computational Biology , Conserved Sequence/genetics , Conserved Sequence/immunology , Drug Design , Epitope Mapping/methods , Epitopes, B-Lymphocyte/genetics , Epitopes, B-Lymphocyte/immunology , Epitopes, T-Lymphocyte/genetics , Epitopes, T-Lymphocyte/immunology , Fructose-Bisphosphate Aldolase/genetics , Fructose-Bisphosphate Aldolase/metabolism , Fungal Proteins/genetics , Fungal Proteins/metabolism , Fungal Vaccines/administration & dosage , Fungal Vaccines/genetics , Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens Class I/metabolism , Histocompatibility Antigens Class I/ultrastructure , Histocompatibility Antigens Class II/immunology , Histocompatibility Antigens Class II/metabolism , Histocompatibility Antigens Class II/ultrastructure , Humans , Immunogenicity, Vaccine/genetics , Molecular Docking Simulation , Protein Structure, Tertiary , Vaccines, Subunit/administration & dosage , Vaccines, Subunit/genetics , Vaccines, Subunit/immunology
9.
Adv Protein Chem Struct Biol ; 125: 25-49, 2021.
Article En | MEDLINE | ID: mdl-33931141

Candida albicans are polymorphic fungal species commonly occurs in a symbiotic association with the host's usual microflora. Certain specific changes in its usual microenvironment can lead to diseases ranging from external mucosal to severally lethal systemic infections like invasive candidiasis hospital-acquired fatal infection caused by different species of Candida. The patient acquired with this infection has a high mortality and morbidity rate, ranging from 40% to 60%. This is an ill-posed problem by its very nature. Hence, early diagnosis and management is a crucial part. Antifungal drug resistance against the first and second generation of antifungal drugs has made it difficult to treat such fatal diseases. After a few dormant years, recently, there has been a rapid turnover of identifying novel drugs with low toxicity to limit the problem of drug resistance. After an initial overview of related work, we examine specific prior work on how a change in oxidative stress can facilitate apoptosis in C. albicans. Subsequently, it was investigated that Candida spp. suppresses the production of ROS mediated host defense system. Here, we have reviewed possibly all the small molecule inhibitors, natural products, antimicrobial peptide, and some naturally derived semi-synthetic compounds which are known to influence oxidative stress, to generate a proper apoptotic response in C. albicans and thus might be a novel therapeutic approach to augment the current treatment options.


Apoptosis/immunology , Candida albicans/immunology , Candidiasis , Opportunistic Infections , Reactive Oxygen Species/immunology , Animals , Candidiasis/immunology , Candidiasis/therapy , Humans , Iatrogenic Disease , Opportunistic Infections/immunology , Opportunistic Infections/therapy
10.
Medicine (Baltimore) ; 100(14): e25459, 2021 Apr 09.
Article En | MEDLINE | ID: mdl-33832156

RATIONALE: Endogenous fungal endophthalmitis (EFE) is a sight-threatening complication of systemic fungemia. As the prevalence rises, treatment remains a challenge especially when there is a failure in first-line treatment or drug-resistant fungus. This case report studies a case of chronic EFE, focusing on the diagnostic procedures, treatment options, monitoring parameters and the treatment outcome. PATIENT CONCERNS: A 64-year-old man with underlying well controlled diabetes mellitus was treated with 2 weeks' course of intravenous antifungal fluconazole for pyelonephritis as his blood culture grew Candida albicans. Concurrently, he complained of 3 months of bilateral painless progressive blurring of vision. At presentation, his visual acuity (VA) was light perception both eyes. Ocular examination revealed non granulomatous inflammation with dense vitritis of both eyes. DIAGNOSIS: He was diagnosed with EFE but the condition responded poorly with the medications. INTERVENTIONS: He was treated with intravitreal (IVT) amphotericin B and fluconazole was continued. Vitrectomy was performed and intraoperative findings included bilateral fungal balls in the vitreous and retina with foveal traction in the left eye. Postoperatively, vision acuity was 6/24, N8 right eye and 2/60, N unable for left eye with extensive left macular scar and hole. Vitreous cultures were negative. He received multiple IVT amphotericin B and was started on topical steroid eye drops for persistent panuveitis with systemic fluconazole. Ocular improvement was seen after switching to IVT and topical voriconazole. Despite this, his ocular condition deteriorated and he developed neovascular glaucoma requiring 3 topical antiglaucoma agents. Panretinal photocoagulation was subsequently performed. OUTCOMES: At 3 months' follow-up, his vision acuity remained at 6/24 for right eye and 2/60 for the left eye. There was no recurrence of inflammation or infection in both eyes. LESSONS: Voriconazole could serve as a promising broad spectrum tri-azole agent in cases of failure in first-line treatment or drug-resistant fungus.


Candida albicans/isolation & purification , Candidiasis/diagnosis , Candidiasis/therapy , Endophthalmitis/diagnosis , Endophthalmitis/therapy , Eye Infections, Fungal/diagnosis , Eye Infections, Fungal/therapy , Antifungal Agents/therapeutic use , Combined Modality Therapy , Humans , Male , Middle Aged , Vitrectomy , Voriconazole/therapeutic use
11.
Ital J Pediatr ; 47(1): 27, 2021 Feb 11.
Article En | MEDLINE | ID: mdl-33573668

BACKGROUND: Invasive fungal infection (IFI) is one of the most challenging complications in children undergoing acute lymphoblastic leukaemia (ALL) treatment, but acute fungal osteomyelitis (OM) is rarely encountered. CASE PRESENTATION: Here, we describe a case of Candida tropicalis osteomyelitis in a 10-year-old patient with Philadelphia chromosome (Ph)-positive ALL. He was on remission induction therapy at the time of neutropenia, and an abscess developed in his right arm. The blood and bone cultures were positive for C. tropicalis. Antibiotics and antifungals were administered. Magnetic resonance imaging of the arm revealed an intraosseous abscess, suggestive of OM. Surgical irrigation and debridement of the bone were performed immediately. The patient was effectively treated with antifungal therapy and ALL treatment. He has fully recovered into complete clinical remission but with visible sequelae on magnetic resonance imaging (MRI). He took oral posaconazole for consolidation until disappearance of the lesion shadows on MRI and received subsequent cycles of chemotherapy in parallel. CONCLUSIONS: In the successful management of Ph-positive ALL, dasatinib, a second-generation Abl-tyrosine kinase inhibitor, is crucial. The recommended treatment for Candida osteomyelitis in Ph-positive ALL patients is a fungicidal agent combined with surgery and modification chemotherapy with dasatinib. The use of combined modalities of treatment seems to be crucial in the successful management of Ph-positive ALL.


Candidiasis/immunology , Candidiasis/microbiology , Dasatinib/therapeutic use , Osteomyelitis/immunology , Osteomyelitis/microbiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Antifungal Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Candida tropicalis , Candidiasis/therapy , Child , Combined Modality Therapy , Debridement , Humans , Magnetic Resonance Imaging , Male , Osteomyelitis/therapy , Philadelphia Chromosome , Remission Induction , Therapeutic Irrigation
12.
CEN Case Rep ; 10(1): 111-114, 2021 02.
Article En | MEDLINE | ID: mdl-32909234

Emphysematous pyelonephritis (EPN) is a necrotizing gas producing infection of the renal parenchyma that commonly occurs in patients with diabetes. EPN requires early diagnosis and treatment due to the possible life-threatening septic complications. We report a rare case of EPN caused by an unfavorable mixed infection of Candida parapsilosis and Finegoldia magna. To our knowledge, this is the first reported case of EPN caused by Finegoldia magna. A 62-year-old male with diabetes mellitus (DM) presented with abdominal pain, shortness of breath, and nausea in which a diagnosis of septic shock was made due to EPN. Our patient first noticed abdominal pain 3 weeks prior to hospital presentation; however, he avoided getting treatment due to a fear of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This patient exhibited deterioration and expired after surgical intervention despite uneventful nephrectomy. This case suggests that medical care avoidance behaviors among patients could potentially complicate their clinical course.


Candida parapsilosis , Candidiasis/therapy , Emphysema/microbiology , Firmicutes , Gram-Positive Bacterial Infections/therapy , Pyelonephritis/microbiology , Time-to-Treatment , COVID-19/psychology , Candidiasis/diagnosis , Delayed Diagnosis , Emphysema/diagnosis , Emphysema/therapy , Fatal Outcome , Fear , Gram-Positive Bacterial Infections/diagnosis , Humans , Male , Middle Aged , Pandemics , Pyelonephritis/diagnosis , Pyelonephritis/therapy , SARS-CoV-2
13.
Probiotics Antimicrob Proteins ; 13(1): 163-172, 2021 02.
Article En | MEDLINE | ID: mdl-32583131

Lactobacilli in the vaginal tract are essential to protect against microbial infections. We therefore focused on isolating vaginal lactobacilli from pregnant women and testing their functional properties. Lactobacilli were isolated from 50 vaginal swabs and the purified isolates were identified by MALDI-TOF MS. Functional properties (antimicrobial activity, organic acids and hydrogen peroxide production, antibiotic susceptibility, auto-aggregation, and hydrophobicity) of selected isolates were tested. Lactobacilli (41 strains) were identified in 58% of swabs with a predominance of Lactobacillus crispatus (48%) followed by L. jensenii (21%), L. rhamnosus (14%), L. fermentum (10%), and L. gasseri (7%). The highest antibacterial activity was determined for L. fermentum and L. rhamnosus. Strong anti-Candida activity was observed for strains L. crispatus, L. fermentum, and L. rhamnosus. Strain L. jensenii 58C possessed the highest production of hydrogen peroxide (6.32 ± 0.60 mg/l). The best lactic acid producer was strain L. rhamnosus 72A (11.6 ± 0.2 g/l). All strains were resistant to fluconazole and metronidazole. The highest auto-aggregation was observed for strain L. crispatus 51A (98.8 ± 0.1% after 24 h). Strain L. rhamnosus 68A showed the highest hydrophobicity (69.1 ± 1.4%). Strains L. fermentum and L. rhamnosus showed high antibacterial activity and hydrophobicity, and strains L. crispatus possessed high auto-aggregation and anti-Candida activity. Thus, these strains alone or in a mix could be used for the preparation of probiotic products for treatment and prevention of vulvovaginal infections of pregnant and non-pregnant women.


Candida/growth & development , Candidiasis , Lactobacillus , Vagina/microbiology , Vaginitis , Vulvitis , Adult , Candidiasis/microbiology , Candidiasis/therapy , Female , Humans , Pregnancy , Vaginitis/microbiology , Vaginitis/therapy , Vulvitis/microbiology , Vulvitis/therapy
14.
Ital J Pediatr ; 46(1): 145, 2020 Oct 06.
Article En | MEDLINE | ID: mdl-33023609

OBJECTIVE: To describe a case of thrombophlebitis associated with Candida infection and to analyze other published reports to define clinical characteristics, prognostic data, diagnostic and therapeutic strategies. STUDY DESIGN: A computerized search was performed without language restriction using PubMed and Scopus databases. An article was considered eligible for inclusion if it reported cases with Candida thrombophlebitis. Our case was also included in the analysis. RESULTS: A total of 16 articles reporting 27 cases of Candida thrombophlebitis were included in our review. The median age of patients was 4 years. In 10 cases there was a thrombophlebitis of peripheral veins; in the remaining cases the deep venous circle was interested. Candida albicans was the most frequently involved fungal species. The most recurrent risk factors were central venous catheter (19/28), broad spectrum antibiotics (17/28), intensive care unit (8/28), surgery (3/28), mechanical assisted ventilation (5/28), total parenteral nutrition (8/28), cancer (2/28), premature birth (6/28), cystic fibrosis (2/28). Fever was the most frequent clinical feature. All children with peripheral and deep thrombophlebitis were given antifungal therapy: amphotericin B was the most used, alone or in combination with other antifungal drugs. Heparin was most frequently used as anticoagulant therapy. Illness was fatal in two cases. CONCLUSION: Candida thrombophlebitis is a rare but likely underdiagnosed infectious complication in pediatric critically ill patients. It is closely connected to risk factors such as central venous catheter, hospitalization in intensive care unit, prematurity, assisted ventilation, chronic inflammatory diseases. Antifungal therapy and anticoagulant drugs should be optimized for each patient and surgical resection is considered in the persistence of illness.


Candidiasis/complications , Candidiasis/microbiology , Thrombophlebitis/microbiology , Amphotericin B/therapeutic use , Anticoagulants/therapeutic use , Antifungal Agents/therapeutic use , Candidiasis/therapy , Child , Child, Preschool , Cross Infection/microbiology , Cross Infection/therapy , Humans , Prognosis , Risk Factors , Thrombophlebitis/therapy
15.
Article En | MEDLINE | ID: mdl-33086415

To describe a case of a recurrent Candida tropicalis otitis externa, media and interna in a dog with an ear polyp. A 9-year-old Irish Setter was presented with 2 episodes of otitis sinistra, left-sided vestibular syndrome and Horner syndrome 7 months apart. At the first episode a benign ear polyp was extracted and Candida tropicalis cultured from the left middle ear. The neurological signs disappeared within 7 days, the Candida infection was more difficult to treat. Seven months later, a polyp was found in the ear again and cytology was consistent with Candida tropicalis. A unilateral left total ear canal ablation with lateral bulla osteotomy was performed and a middle ear culture confirmed Candida tropicalis. Treatment led to resolution of clinical signs. Candida tropicalis, an emerging pathogen, should be considered in cases of recurrent yeast otitis and may be difficult to treat.


Candida tropicalis , Candidiasis , Dog Diseases , Otitis , Polyps , Animals , Candidiasis/diagnosis , Candidiasis/microbiology , Candidiasis/therapy , Candidiasis/veterinary , Dogs , Ear/microbiology , Ear/surgery , Osteotomy/veterinary , Otitis/diagnosis , Otitis/microbiology , Otitis/therapy , Otitis/veterinary , Polyps/diagnosis , Polyps/microbiology , Polyps/therapy , Polyps/veterinary
16.
Adv Wound Care (New Rochelle) ; 9(8): 462-471, 2020 08.
Article En | MEDLINE | ID: mdl-32857020

Objective: In recent years, reticulated open-cell foam-based closed-incision negative pressure therapy (ROCF-ciNPT) has shown effectiveness in management of various postoperative incisions. These dressings consist of a skin interface layer that absorbs fluid from the skin surface and reduces the potential for microbial colonization within the dressing by means of ionic silver. This study examines the ability of silver to reduce the bioburden within the dressing as well as the localized effect due to potential silver mobility. Approach: Ability of silver to reduce bioburden within the ROCF-ciNPT dressing was assessed using Staphylococcus aureus, Pseudomonas aeruginosa, and Candida spp. Furthermore, silver mobility was assessed using an in vitro skin model to study the zone of inhibition along with released silver quantification. Using a porcine model, diffusion of silver into blood and tissue was studied using emission spectrometry and histology. Results: Microbial growth in the ROCF-ciNPT dressing was significantly reduced (∼2.7-4.9 log reduction) compared to a silver-free negative control. No zone of inhibition was observed for microbial colonies for up to 7 days with minimal localized silver release (<5.5 ppm release). In vivo studies demonstrated no measurable concentration (<0.2 µg/g) of silver in the blood, urine, feces, kidney, and liver tissue biopsy. Innovation: This study provides an important insight into silver concentration and mobility within the ROCF-ciNPT dressing, given emerging concerns associated with potential silver cytotoxicity. Conclusion: These results indicate the concentration of silver (0.019% silver by weight) in the ROCF-ciNPT dressings has been adequate to reduce bioburden within the skin interface layer, while severely limiting the amount of silver leaching out.


Candida/drug effects , Candidiasis/therapy , Negative-Pressure Wound Therapy/methods , Pseudomonas Infections/therapy , Silver/pharmacokinetics , Staphylococcal Infections/therapy , Staphylococcus aureus/drug effects , Surgical Wound Infection/therapy , Surgical Wound/therapy , Animals , Bandages , Candidiasis/blood , Candidiasis/microbiology , Candidiasis/urine , Disease Models, Animal , Male , Pseudomonas Infections/blood , Pseudomonas Infections/microbiology , Pseudomonas Infections/urine , Pseudomonas aeruginosa/drug effects , Silver/blood , Silver/urine , Staphylococcal Infections/blood , Staphylococcal Infections/microbiology , Staphylococcal Infections/urine , Surgical Wound/blood , Surgical Wound/urine , Surgical Wound Infection/blood , Surgical Wound Infection/microbiology , Surgical Wound Infection/urine , Swine , Treatment Outcome , Wound Healing
17.
Hand Clin ; 36(3): 345-353, 2020 08.
Article En | MEDLINE | ID: mdl-32586461

Systemic conditions are associated with higher rates of hand and upper extremity infections, leading to more severe and atypical presentations. Understanding the unique problems associated with some of the most common systemic conditions, including human immunodeficiency virus, diabetes mellitus, and rheumatoid arthritis, can assist the hand surgeon in diagnosing and treating infection in these patients. This article reviews the most common presentation of hand infections for these patients and summarizes current approaches to the management of hand infections for patients with common immunocompromising conditions.


Hand/microbiology , Hand/virology , Osteomyelitis/complications , Soft Tissue Infections/complications , Abscess/complications , Abscess/diagnosis , Abscess/therapy , Anti-Infective Agents/therapeutic use , Arthritis, Rheumatoid/complications , Candidiasis/diagnosis , Candidiasis/therapy , Diabetes Complications , Fasciitis, Necrotizing/diagnosis , Fasciitis, Necrotizing/therapy , HIV Infections/complications , Herpes Simplex/diagnosis , Herpes Simplex/therapy , Humans , Immunocompromised Host , Osteomyelitis/diagnosis , Osteomyelitis/therapy , Papillomavirus Infections/diagnosis , Papillomavirus Infections/therapy , Soft Tissue Infections/diagnosis , Soft Tissue Infections/therapy , Transplant Recipients , Tuberculosis/complications
18.
Mycopathologia ; 185(3): 545-554, 2020 Jun.
Article En | MEDLINE | ID: mdl-32318935

Candida infection is common, while Candida parapsilosis infection in the knee joint is rare. Local symptoms of Candida infections in the knee are atypical, rarely associated with systemic symptoms, and difficult to distinguish from other types of knee arthritis. We here report a special case of C. parapsilosis infections in the knee joint. A patient had previously undergone knee puncture in a private clinic for the treatment of osteoarthritis and developed a left knee joint infection with C. parapsilosis. However, the patient only showed more severe local knee symptoms, and there was no systemic manifestation associated with any Candida infection. Surprisingly, after receiving ozone lavage, the patient showed symptoms of a systemic infection such as fever and chills. There was no positive finding in the blood cultures. Finally, the synovial fluid cultures showed a C. parapsilosis infections. After antifungal treatment and another knee ozone therapy, the patient did not experience recurrence of the infections. It is suggested that in this special case, the strong sterilization with ozone caused the destruction of C. parapsilosis, leading to a transient systemic toxin reaction. In addition, we reviewed the 17 cases of C. parapsilosis infections that have been reported thus far.


Candida parapsilosis , Candidiasis/therapy , Knee Joint/microbiology , Oxidants, Photochemical/therapeutic use , Ozone/therapeutic use , Drainage , Humans , Knee Joint/diagnostic imaging , Magnetic Resonance Imaging , Male , Middle Aged , Ozone/administration & dosage , Therapeutic Irrigation
19.
Pediatr Ann ; 49(4): e170-e175, 2020 Apr 01.
Article En | MEDLINE | ID: mdl-32275761

Vaginitis presents with vaginal discharge, odor, pruritis, and/or discomfort and affects up to 75% of girls and women over the course of their lifetimes, with most women experiencing their first episode during adolescence. Given the prevalence of this disorder, this article aims to provide an overview of vaginitis for the general pediatrician. We start with prepubertal etiologies of vaginitis, then discuss pubertal and normal physiologic discharge, and then focus on the most common etiologies of adolescent vulvovaginitis. The three most common microbial etiologies of vaginitis (bacterial vaginosis, vulvovaginal candidiasis, and trichomonas) are addressed, as well as their diagnosis and treatment in adolescents. [Pediatr Ann. 2020;49(4):e170-e175.].


Vaginal Discharge/etiology , Vulvovaginitis , Adolescent , Bacterial Infections/complications , Bacterial Infections/diagnosis , Bacterial Infections/therapy , Candidiasis/complications , Candidiasis/diagnosis , Candidiasis/therapy , Child , Female , Humans , Trichomonas Infections/complications , Trichomonas Infections/diagnosis , Trichomonas Infections/therapy , Vulvovaginitis/diagnosis , Vulvovaginitis/etiology , Vulvovaginitis/physiopathology , Vulvovaginitis/therapy
...